lubiprostone

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 333963-40-9

Where It Comes From

27 FDA-registered drug labelers
Advanced Rx of Tennessee, LLC
American Health Packaging
Asclemed USA, Inc.
Camber Pharmaceuticals, Inc.
Catalent Pharma Solutions, LLC
Chirogate International Inc
Direct Rx
Dr. Reddy's Laboratories Inc.
Dr.Reddy's Laboratories Limited
Everlight Chemical Industrial Corporation Kuanyin II Plant
Golden State Medical Supply, Inc.
MSN Laboratories Private Limited
Natco Pharma USA LLC
Northstar Rx LLC
Par Health USA, LLC
Patheon Softgels Inc.
Proficient Rx LP
Quality Care Products, LLC
SpecGx LLC
SUCAMPO PHARMA LIMITED LIABILITY COMPANY
Sun Pharmaceutical Industries, Inc.
Takeda Pharmaceuticals America, Inc.
Teva Pharmaceuticals, Inc.
YS Life Science Co., Ltd.
Zhejiang Ausun Pharmaceutical Co., Ltd.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • Lubiprostone
  • Amitiza
  • Amitza
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS333963-40-9
PubChem CID157920
DTXSIDDTXSID80861338
FormulaC20H32F2O5
Mol. Weight390.5 g/mol
SMILESCCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F

Data Sources

1579202026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/lubiprostone/cids/JSON

Archive: data/sources/pubchem_name/lubiprostone.json

CAS 333963-40-92026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json